Niams requests the purchase of sequencing reagent kits for our illumina novaseq 6000 sequencer. These kits are extremely essential to continue the sequencing operation of our core facility.

Ended Awarded Last action

Contract number
75N92B20F00021
Awardee
Awarding agency
Obligated
$248,412

Award facts

Contract value 100% obligated
$248,412.08 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6810 Chemicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92122, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a delivery order to Illumina, Inc. on July 14, 2020, with a ceiling value of $248,412.08 for sequencing reagent kits for an Illumina NovaSeq 6000 sequencer to support the institute's core facility sequencing operations.

Place of performance is San Diego, CA 92122. The order is priced on a firm fixed-price basis and has an ultimate completion date of September 2, 2020. No set-aside was used.

Quick answers

Who was awarded contract 75N92B20F00021?

75N92B20F00021 was awarded to Illumina, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on July 14, 2020.

How much is contract 75N92B20F00021 worth?

The government has obligated $248,412 on 75N92B20F00021.

Is contract 75N92B20F00021 an order under another contract?

Yes. 75N92B20F00021 is a delivery order under HHSN268201500004I, an indefinite delivery contract.

Was contract 75N92B20F00021 competed?

The extent of competition for 75N92B20F00021 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award